Exelixis
EXEL
#1698
Rank
NZ$16.86 B
Marketcap
$59.04
Share price
0.24%
Change (1 day)
70.39%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $83.72 NZD on 2000-07-26

Lowest end of day price: $2.19 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$56.65-0.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$81.02-0.25%๐Ÿ‡ซ๐Ÿ‡ท France
$167.14 0.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$98.47 0.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$491.47 0.43%๐Ÿ‡บ๐Ÿ‡ธ USA
$262.50 0.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.36-0.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.39 1.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.50 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA